Multiple sclerosis (MS) is a chronic, disabling, inflammatory disease that damages your nerves. People with MS may live roughly seven years less than the general population, with an average life ...
The first large scale study in the U.S. on the mortality of patients with multiple sclerosis (MS) has been published and provides new information about the life expectancy of people with the disease.
A multiple sclerosis diagnosis can feel overwhelming, especially when you start researching what it means for your future. Here’s what you need to know upfront — while multiple sclerosis may impact ...
Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new ...
Individuals with myasthenia gravis (MG) lived 15 to 19 years longer than those with multiple sclerosis (MS), across 4 ...
As the life expectancy of individuals with multiple sclerosis (MS) increases, understanding how ageing interacts with disease progression and quality of life has become a priority. Ageing with MS ...
Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system associated with a tangible reduction in life expectancy and a spectrum of health outcomes that extend beyond ...
Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new ...
Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results